New Key Statistics Module, Z-Score and F-Score
OTCPK:ZLDAF Key Ratios
Market Cap $ M | 2.80 |
Enterprise Value $ M | 3.90 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 14.23 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.17 |
Beneish M-Score | -5.92 |
10-y EBITDA Growth Rate % | -4.20 |
5-y EBITDA Growth Rate % | -0.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.16 |
EV-to-EBITDA | -0.16 |
PEG | -- |
Shares Outstanding M | 11.35 |
Net Margin (%) | -13,057.71 |
Operating Margin % | -2,570.61 |
Pre-tax Margin (%) | -13,235.48 |
Quick Ratio | 0.15 |
Current Ratio | 0.43 |
ROA % (ttm) | -151.53 |
ROE % (ttm) | -177.38 |
ROIC % (ttm) | -31.82 |
Dividend Yield % | -- |
Altman Z-Score | -1.29 |
ZLDAF Number of Guru Trades
ZLDAF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ZLDAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ZLDAF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zelira Therapeutics Ltd Insider Transactions
No Available Data
News about OTCPK:ZLDAF
Total 0- 1